CA 2024 * | - | CA 2025 * | 1,04 M 762 k 694 k | Capitalisation | 26,09 M 19,07 M 17,36 M |
---|---|---|---|---|---|
Résultat net 2024 * | -74 M -54,1 M -49,24 M | Résultat net 2025 * | -54 M -39,48 M -35,93 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | 25 x |
PER 2024 * |
-0,24
x | PER 2025 * |
-0,34
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 80,93% |
Dernier transcript sur Aptose Biosciences
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27/06/22 |
Chief Tech/Sci/R&D Officer | - | 01/11/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19/09/07 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13/09/22 |
Mark Vincent
BRD | Director/Board Member | 71 | 19/09/07 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,90% | 42,68 Md | |
-3,92% | 42,4 Md | |
+45,32% | 40,04 Md | |
-6,20% | 28,31 Md | |
+6,36% | 24,94 Md | |
-21,47% | 18,96 Md | |
+27,57% | 12,3 Md | |
-2,92% | 11,95 Md | |
-1,92% | 11,55 Md |